Michael Murphy
About Michael Murphy
Michael Murphy is the Manager of Market Access Analytics at Alkermes, with over 8 years of experience in market access and patient access roles within the company.
Current Role at Alkermes
Michael Murphy currently serves as the Manager of Market Access Analytics at Alkermes. Transitioning into this role in 2019, Michael leverages his extensive background in market access and patient access to drive strategic insights and data-driven decision-making processes. His responsibilities likely include overseeing analytics initiatives, managing data sets related to market access, and providing actionable insights to support the company's objectives.
Previous Roles at Alkermes
Before becoming Manager of Market Access Analytics, Michael Murphy held several key roles at Alkermes. He served as a Senior Market Access Analyst for one year from 2018 to 2019. Prior to that, he was a Patient Access Analyst from 2016 to 2018 and a Reimbursement and Patient Access Specialist from 2015 to 2016. Each of these roles enhanced his expertise in patient access and reimbursement processes, preparing him for his current management position.
Educational Background
Michael Murphy holds a Master of Business Administration (MBA) from the Manning School of Business at UMass Lowell, completed over three years from 2018 to 2021. He also has a background in Secondary Education and History, having studied these subjects at Framingham State College from 2009 to 2012. His educational journey began at Boston Latin School. This diverse academic background contributes to his analytical skills and strategic thinking in his current role.
Early Career in Healthcare
Michael Murphy's career in healthcare started as a Pharmacy Technician at Pelham Community Pharmacy, where he worked for eight years from 2004 to 2012. This role provided him with foundational knowledge in the healthcare industry and patient interactions. Following this, he worked as a Case Reimbursement Specialist at EMD Serono, Inc. for three years from 2012 to 2015, further deepening his understanding of reimbursement processes and patient access.